Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Evolocumab for Heart Disease
Recruiting1 awardPhase 3
Southampton, New York
This trial will see if evolocumab, a cholesterol-lowering drug, can prevent major cardiovascular events in high-risk adults who have not had a heart attack or stroke.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service